THOMAS BARKER

-Issues relating to surprise medical billing legislation and transparency requirements.

-Issues relating to surprise medical billing legislation and transparency requirements.

-Issues relating to surprise medical billing legislation and transparency requirements.

-Medicare Part B and D payment for drugs -Issues related to the repeal of the non-interference clause in Part D

-Implementation of Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development -Implementation of 21st Century Cures (P.L. 114-255) -Issues related to pandemic and seasonal influenza vaccine development -Reauthorization of Pandemic and All Hazards Preparedness (P.L. 109-417) -Issues related to over-the-counter drug and cosmetic reform legislation -Issues related to Right to Try -Issues related to drug and insulin pricing

-Medicare Part B and D payment for drugs -Issues related to the repeal of the non-interference clause in Part D

-Implementation of Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development -Implementation of 21st Century Cures (P.L. 114-255) -Issues related to pandemic and seasonal influenza vaccine development -Reauthorization of Pandemic and All Hazards Preparedness (P.L. 109-417) -Issues related to over-the-counter drug and cosmetic reform legislation -Issues related to Right to Try -Issues related to drug and insulin pricing

-Medicare Part B and D payment for drugs -Issues related to the repeal of the non-interference clause in Part D

-Implementation of Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development -Implementation of 21st Century Cures (P.L. 114-255) -Issues related to pandemic and seasonal influenza vaccine development -Reauthorization of Pandemic and All Hazards Preparedness (P.L. 109-417) -Issues related to over-the-counter drug and cosmetic reform legislation -Issues related to Right to Try -Issues related to drug and insulin pricing

-Implementation of the Affordable Care Act of 2010 (P.L. 111-148) -Implementation of the Health Care and Education Reconciliation Act of 2010 (P.L. 111-152) -Implementation of Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development -Implementation of 21st Century Cures (P.L. 114-255) -Issues related to pandemic and seasonal influenza vaccine development -Reauthorization of Pandemic and All Hazards Preparedness (P.L. 109-417) -Issues related to over-the-counter drug and cosmetic reform legislation -Issues related to Right to Try -Issues related to drug and insulin pricing

-Medicare Part B and D payment for drugs -Issues relating to IPAB in S. 251 "Protecting Medicare from Executive Action of 2017" -Issues related to the repeal of the non-interference clause in Part D

-Medicare Part B and D payment for drugs -Issues relating to IPAB in S. 251 "Protecting Medicare from Executive Action of 2017" -Issues related to the repeal of the non-interference clause in Part D

-Implementation of the Affordable Care Act of 2010 (P.L. 111-148) -Implementation of the Health Care and Education Reconciliation Act of 2010 (P.L. 111-152) -Implementation of Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development -Implementation of 21st Century Cures (P.L. 114-255) -Issues related to pandemic and seasonal influenza vaccine development -Reauthorization of Pandemic and All Hazards Preparedness (P.L. 109-417) -Issues related to over-the-counter drug and cosmetic reform legislation -Issues related to Right to Try -Issues related to drug and insulin pricing

-Implementation of Sec. 16007 of the 21st Century Cures Act (Pub. L. 114-255) -Reforms to the Medicare competitive bidding program -Payment issues relating to complex rehabilitation wheelchairs and portable oxygen

-Medicare inpatient reimbursement.

-Medicare coverage of home infusion drugs and biologics, including payment for durable medical equipment drugs and biologics. -21st Century Cures (P.L. 114-255): Sec. 5012 - Medicare Coverage of Home Infusion Therapy. -H.R. 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act -H.R. 3178 - Medicare Part B Improvement Act of 2017

-Implementation of Sec. 16007 of the 21st Century Cures Act (Pub. L. 114-255). -Reforms to the Medicare competitive bidding program. -Payment issues relating to complex rehabilitation wheelchairs and portable oxygen.

-Implementation of Sec. 16007 of the 21st Century Cures Act. -Reforms to the Medicare competitive bidding program. -Payment issues relating to complex rehabilitation wheelchairs and portable oxygen.

-Medicare coverage of home infusion drugs and biologics, including payment for durable medical equipment drugs and biologics. -21st Century Cures (P.L. 114-255): Sec. 5012 - Medicare Coverage of Home Infusion Therapy. -H.R. 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act -H.R. 3178 - Medicare Part B Improvement Act of 2017

-Medicare Part B payment for drugs.

-Implementation of the Affordable Care Act of 2010 (P.L. 111-148). -Implementation of the Health Care and Education Reconciliation Act of 2010 (P.L. 111-152). -Implementation of Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development. -Implementation of 21st Century Cures (P.L. 114-255). -Issues related to pandemic and seasonal influenza vaccine development. -Issues related to over-the-counter drug and cosmetic reform legislation.

-Implementation of the Affordable Care Act of 2010 (P.L. 111-148). -Implementation of the Health Care and Education Reconciliation Act of 2010 (P.L. 111-152). -Implementation of Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development. -Implementation of H.R. 6 - 21st Century Cures (P.L. 114-255). -S.2013 Trickett Wendler Right to Try Act of 2017. -H.R. 2430 and S. 932, FDA Reauthorization Act. -Issues related to Zika vaccine development. -Issues related to over-the-counter drug and cosmetic reform legislation.

-Medicare Part B payment for drugs.

-Medicare coverage of home infusion drugs and biologics, including payment for durable medical equipment drugs and biologics. -H.R. 6 - 21st Century Cures (P.L. 114-255): Sec. 5012 - Medicare Coverage of Home Infusion Therapy. -H.R. 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act -H.R. 3178 - Medicare Part B Improvement Act of 2017

-Reforms to the Medicare competitive bidding program for durable medical equipment. -Issues involving payment adjustments in non-competitive bidding areas. -Payment issues involving complex rehabilitation technology accessories relating to competitive bidding and portable oxygen.

-Implementation of the Affordable Care Act of 2010 (P.L. 111-148). -Implementation of the Health Care and Education Reconciliation Act of 2010 (P.L. 111-152). -Implementation of Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development. -H.R. 6 - 21st Century Cures (P.L. 114-255).

-Medicare Part B payment for drugs.

FY 2018 Inpatient Prospective Payment System Proposed Rule

-Medicare coverage of home infusion drugs and biologics, including payment for durable medical equipment drugs and biologics. -H.R. 6 - 21st Century Cures (P.L. 114-255): Sec. 5012 - Medicare Coverage of Home Infusion Therapy. -H.R. 3163 - Medicare Part B Home Infusion Services Temporary Transitional Payment Act -H.R. 3178 - Medicare Part B Improvement Act of 2017

-Inpatient Prospective Payment System under Part A of Medicare.

-Implementation of the Affordable Care Act of 2010 (P.L. 111-148). -Implementation of the Health Care and Education Reconciliation Act of 2010 (P.L. 111-152). -Implementation of Orphan Drug Act of 1983 (P.L. 97-414) and orphan drug development. -H.R. 6 - 21st Century Cures (P.L. 114-255).

-Medicare Part B payment for drugs.

-Medicare coverage of home infusion drugs and biologics, including payment for durable medical equipment drugs and biologics. -H.R. 6 - 21st Century Cures (P.L. 114-255): Sec. 5012 - Medicare Coverage of Home Infusion Therapy.

- Implementation of the Affordable Care Act of 2010 (P.L. 111-148). - Implementation of the Health Care and Education Reconciliation Act of 2010 (P.L. 111-152). - Implementation of Orphan Drug Act of 1983 (P.L 97-414) and orphan drug development. - H.R. 6 - 21st Century Cures (P.L. 114-255).

- Medicare Part B payment for drugs.

Medicare coverage of home infusion drugs and biologics, including payment for durable medical equipment drugs and biologics. S. 275 and H.R. 605 - Medicare Home Infusion Site of Care Act of 2015. H.R. 6 - 21st Century Cures (P.L. 114-255): Sec. 5012 - Medicare Coverage of Home Infusion Therapy.

Section 603 of the Bipartisan Budget Act.

Section 603 of the Bipartisan Budget Act.

Medicare coverage of home infusion drugs and bioloigcals; payment for durable medical equipment drugs and biologicals. S. 275: Medicare Home Infusion Site of Care Act of 2015. H.R. 605: Medicare Home Infusion Site of Care Act of 2015.

Implementation of the "Affordable Care Act of 2010 (P.L. 111-148), and Implementation of Health Care and Education Reconciliation Act (P.L. 111-152) (Biosimilars). Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). Implementation of Orphan Drug Act and orphan drug development. House Committee on Energy & Commerce 21st Century Cures initiative.

Medicare Part B payment for drugs.

Medicare Part B payment for drugs.

Implementation of the "Affordable Care Act of 2010 (P.L. 111-148), and Implementation of Health Care and Education Reconciliation Act (P.L. 111-152) (Biosimilars). Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). Implementation of Orphan Drug Act and orphan drug development. House Committee on Energy & Commerce 21st Century Cures initiative.

Medicare coverage of home infusion drugs and bioloigcals; payment for durable medical equipment drugs and biologicals. S. 275: Medicare Home Infusion Site of Care Act of 2015. H.R. 605: Medicare Home Infusion Site of Care Act of 2015.

Medicare Part B payment for drugs.

Implementation of the "Affordable Care Act of 2010 (P.L. 111-148), and Implementation of Health Care and Education Reconciliation Act (P.L. 111-152) (Biosimilars). Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). Implementation of Orphan Drug Act and orphan drug development. House Committee on Energy & Commerce 21st Century Cures initiative.

Medicare coverage of home infusion drugs and bioloigcals; payment for durable medical equipment drugs and biologicals. S. 275: Medicare Home Infusion Site of Care Act of 2015. H.R. 605: Medicare Home Infusion Site of Care Act of 2015.

Representation of client regarding implementation of section 603 of Public Law 114-74.

Implementation of the "Affordable Care Act of 2010 (P.L. 111-148), and Implementation of Health Care and Education Reconciliation Act (P.L. 111-152) (Biosimilars). Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). Implementation of Orphan Drug Act and orphan drug development. House Committee on Energy & Commerce 21st Century Cures initiative.

Medicare Part B payment for drugs.

Medicare coverage of home infusion drugs and bioloigcals; payment for durable medical equipment drugs and biologicals. S. 275: Medicare Home Infusion Site of Care Act of 2015. H.R. 605: Medicare Home Infusion Site of Care Act of 2015.

Representation of client regarding implementation of section 603 of Public Law 114-74.

Exemption of off-campus outpatient facilities from budget deal pay cut

Medicare coverage of home infusion drugs and bioloigcals; payment for durable medical equipment drugs and biologicals

Regulatory treatment of American health benefit exchanges.

Implementation of the "Affordable Care Act of 2010 (P.L. 111-148), and Implementation of Health Care and Education Reconciliation Act (P.L. 111-152) (Biosimilars). Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (Pub.L. 112-144). Implementation of Orphan Drug Act and orphan drug development. House Committee on Energy & Commerce 21st Century Cures initiative.

Medicare Part B payment for drugs.

Regulatory treatment of American health benefit exchanges.

Regulatory treatment of American health benefit exchanges.

Patient Protection and Affordable Care Act.

Medicare and Medicaid coverage and reimbursement issues.

Medicare and Medicaid coverage and reimbursement issues.

Medicare and Medicaid coverage and reimbursement issues.